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Double-strand  breaks  (DSBs)  are  a 
dangerous  form  of  DNA  damage. 
Unrepaired or misrepaired DNA ends 
can  cause  detrimental  outcomes  for 
cells  and  organisms,  including  cell 
death,  chromosomal  instability,  and 
neoplastic  transformation  (Mills  et  al., 
2003). These catastrophic lesions are 
generated  during  normal  metabolic 
processes such as DNA replication or 
upon  exposure  to  exogenous  agents 
such  as  ionizing  radiation  or  cer-
tain  chemotherapeutic  compounds. 
Several  pathways  exist  that  recog-
nize  and  repair  these  lesions,  includ-
ing  the  nonhomologous  end-joining 
(NHEJ) pathway, which serves to pro-
tect  and  directly  ligate  broken  ends 
(Haber,  2000).  Remarkably,  despite 
the inherent risks, there are examples 
throughout  nature  where  organisms 
have  evolved  systems  to  intentionally 
induce  DSBs.  These  processes  usu-
ally  function  to  increase  diversity  of
species  or  somatic  cells  by  initiating 
the rearrangement of DNA at specific 
regions of  the genome. An  incredible 
example  of  this  is  V(D)J  recombina-
tion,  which  occurs  during  B  and  T 
lymphocyte  development  to  generate 
the  vast  diversity  of  antigen  recep-
tor  genes  that  form  the  basis  of  the 
adaptive  arm  of  our  immune  system. 
Although  this  process  is  initiated  by 
lymphoid-specific  factors,  the  rear-




discovered:  Ku70,  Ku80,  the  DNA-
dependent  protein  kinase  catalytic 
subunit (DNA-PKcs), Artemis, XRCC4 
and  DNA  Ligase  IV.  Ku70  and  Ku80 
comprise a heterodimer  that binds  to 
DNA ends  and  recruits DNA-PKcs,  a 
serine/threonine protein kinase. DNA-
PKcs forms a functional complex with 






tures  containing  single-  to  double-




is  provided  by  Ligase  IV  in  complex 
with  the  XRCC4  cofactor.  Together, 
these  six  proteins  possess  the major 
activities  required  for  NHEJ,  which 
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A major pathway for repair of DNA double-strand breaks is nonhomologous end-joining 
(NHEJ). In this issue of Cell, Buck et al. (2006a) and Ahnesorg et al. (2006) report the discovery 
of a new NHEJ factor called Cernunnos-XLF. Both groups report that this protein is mutated 
in a rare inherited human syndrome characterized by severe immunodeficiency, develop-
mental delay, and hypersensitivity to agents that cause DNA double-strand breaks.
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found  mutated  in  rare  inherited  syn-
dromes  (O’Driscoll  et  al.,  2004).  The 
individuals  suffer  from  whole-body 
and cellular hypersensitivity to ionizing 
radiation  and  DNA-damaging  che-
motherapeutic  compounds  and  are 
immunocompromised  due  to  defec-
tive  V(D)J  recombination.  Addition-
ally,  several  of  the  Ligase  IV-deficient 
patients  have  severe  developmental 
delay  including  microcephaly,  which 
likely reflects the need for this ligase in 
all end-joining reactions whereas only 





mice  (Rooney  et  al.,  2004). Recently, 
intriguing findings were reported from 






the  known NHEJ  genes,  thus  raising 
the  exciting  possibility  that  an  NHEJ 
factor remained undiscovered.
The  hunt  for  this  new  NHEJ  fac-
tor has now ended with  two groups 
reporting  its  identification  in  this 
issue  of  Cell.  de  Villartay  and  col-
leagues  (Buck  et  al.,  2006a)  have 
given  it  the  name  Cernunnos  (an 
enigmatic Celtic god of the hunt, the 
underworld,  fertility,  and  possibly 
more),  whereas  Jackson  and  col-
leagues (Ahnesorg et al., 2006) have 
chosen the descriptive name XLF for 
XRCC4-like  factor. We  shall  refer  to 
it  as Cernunnos-XLF  by  fusing  both 
names in alphabetical order.
The  two  studies  used  different 
approaches  to  discover  Cernunnos-
XLF. de Villartay and colleagues (Buck 
et  al.,  2006a)  identified  a  group  of 
patients  with  phenotypes  consistent 
with  an  NHEJ  defect.  Chief  among 









tion,  microcephaly,  and mental  retar-
dation, which likely result from general
inability  to  repair  spontaneous  DNA
damage throughout the body. Having 
identified  a  small  cohort  of  patients,
they  then  determined  that  their  cells 
exhibited  increased  radiosensitivity, 
DNA DSB repair defects, and impaired 
V(D)J  recombination.  After  excluding 
the six known NHEJ factors, they used 
an elegant strategy to clone the gene 
by  cDNA  complementation  of  cellu-
lar sensitivity  to a DNA DSB-inducing 









screen  to  identify  XRCC4-interacting 
proteins. One positive clone of interest
was  found  to  be  an  uncharacterized 
human open  reading  frame encoding 
a  33  kDa  protein.  Although  standard 
sequence analysis did not reveal con-
served  domains  suggesting  a  DNA-
repair  role,  computer  algorithms  pre-








in  cells  where  Cernunnos-XLF  activ-
ity  was  blocked  by  RNA  interference




was  identified  rapidly  thereafter  with 
the  finding  that  the  Cernunnos-XLF 
protein  could  not  be  detected  in  the 
2BN  cultured  cell  line  and  its  cDNA 
rescued the cellular defects.
Clues to the function of Cernunnos-
XLF  can  be  gleaned  from  the  initial 
analyses of the molecular phenotypes 
of  Cernunnos-XLF-deficient  cells. 
Cells  lacking  DNA-PKcs  or  Artemis 
exhibit less sensitivity to ionizing radia-
tion and a milder DSB-joining defect in 
comparison  to  Ku70,  Ku80,  XRCC4, 
and Ligase IV deficiencies, supporting 
Figure 1. Nonhomologous End-Joining 
in Mammalian Cells
The Ku70/Ku80 heterodimer forms a hollow ring 






plexes with  XRCC4,  Ligase  IV,  or  XRCC4  and 
Ligase IV simultaneously. The exact nature of the 
active complex is currently undefined, but could 









tion  during  all  NHEJ  events  (Rooney 
et  al.,  2004).  The  direct  interaction 
of  Cernunnos-XLF  with  the  XRCC4-
Ligase  IV  complex  and  similar  levels 
of  ionizing  radiation  sensitivities  and 
DSB-repair  defects  exhibited  by Cer-
nunnos-XLF- and XRCC4- or Ligase IV-
deficient cells suggests that this newly 
discovered  factor  may  function  in  all 
NHEJ  events  (see  Figure  1).  Clearly, 
however,  definitive  conclusions  await 




in  processing  and  ligating  DNA  ends 
generated during V(D)J recombination. 




sequences  flanking  V,  D,  and  J  cod-
ing segments (Fugmann et al., 2000). 
Cleavage  by  RAG1/2  generates  two 
different end structures: 5′ phosphor-





Ku70,  Ku80,  XRCC4,  and  Ligase  IV, 
are  required  for  both  coding  and  RS 
joint  formation.  The  significant  V(D)J 
recombination defects  in both coding 
and RS end joining in Cernunnos-XLF-









What  is  the  exact  role  of  Cernun-
nos-XLF in DNA DSB repair and V(D)J
recombination? Ahnesorg et al. (2006) 
suggest  that  Cernunnos-XLF  may 
serve  as  a  bridge  between  XRCC4-
Ligase  IV and the other NHEJ  factors 




inactive  multimeric  states  of  XRCC4 
(Figure  1).  Alternatively,  Cernunnos-
XLF may participate in reconfiguration 
of the end bound NHEJ factors to allow 
XRCC4-Ligase  IV  access  to  the DNA 
termini.  It  will  be  interesting  to  deter-
mine  how Cernunnos-XLF  interaction 
with  XRCC4-Ligase  IV modulates  the 
NHEJ  ligation  activity  and  whether 
its  functions  are  influenced  by  phos-
phorylation  mediated  by  DNA-PKcs.
Clearly,  careful  biochemical  analyses 
of  interactions  between  the  seven 
known NHEJ  factors are essential  for 
our  understanding  of  end  joining  in 
mammalian cells.







deficiencies  also  display  significant 
differences  among  affected  individu-
als with distinct mutations (Buck et al., 
2006b; Ege et al., 2005; O’Driscoll et 
al.,  2004).  Detailed  biochemical  and 
genetic analyses of the disease-asso-
ciated  variants  promise  to  shed  light 
on the reasons for such variability.
Although  the  characterized  NHEJ 
syndromes  are  rare,  the  variability  in 
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